Similar articles

• Bisoprolol prevents mortality and myocardial infarction after vascular surgery.

  Dickerson LM, Carek PJ. Dickerson LM, et al. J Fam Pract. 2000 Mar;49(3):203-4. J Fam Pract. 2000. PMID: 10735475 No abstract available.
• Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

  Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E. Schouten O, et al. Am Heart J. 2004 Dec;148(6):1047-52. doi: 10.1016/j.ahj.2004.05.046. Am Heart J. 2004. PMID: 15632892 No abstract available.
• Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).

  Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E. Böhm M, et al. Z Kardiol. 2003 Aug;92(8):668-76. doi: 10.1007/s00392-003-0959-7. Z Kardiol. 2003. PMID: 12955414 Clinical Trial.
• Perioperative strokes and beta-blockade.

  Poldermans D, Schouten O, van Lier F, Hoeks SE, van de Ven L, Stolker RJ, Fleisher LA. Poldermans D, et al. Anesthesiology. 2009 Nov;111(5):940-5. doi: 10.1097/ALN.0b013e3181ba3bf4. Anesthesiology. 2009. PMID: 19786861 Review. No abstract available.
• Influence of beta-blockers on the outcome of at risk patients.

  Priebe HJ. Priebe HJ. Minerva Anestesiol. 2009 May;75(5):319-23. Minerva Anestesiol. 2009. PMID: 19412151 Review.